lifestyle.thedishh.com

Author: LB Pharmaceuticals Inc

LB Pharmaceuticals Appoints R&D Biotech Executive Robert Lenz, M.D., Ph.D. to Board of Directors

March 9, 2026
LB Pharmaceuticals to Participate in Upcoming March Investor Events

March 4, 2026
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

February 10, 2026
LB Pharmaceuticals Announces $100.0 Million Private Placement

February 7, 2026
LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development Program

January 26, 2026
LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel

January 21, 2026